117 related articles for article (PubMed ID: 9575594)
1. [A trial of the use of the low-molecular heparin sulodexide in the therapy of diabetic nephropathy].
Zalevskaia AG; Astamirova KhS; Karpova IA; Popova SG
Ter Arkh; 1998; 70(3):71-4. PubMed ID: 9575594
[TBL] [Abstract][Full Text] [Related]
2. [The efficacy of Sulodexide--a low-molecular heparin--in the therapy of diabetic nephropathy].
Shestakova MV; Chugunova LA; Vorontsov AV; Dedov II
Ter Arkh; 1997; 69(6):34-7. PubMed ID: 9297270
[TBL] [Abstract][Full Text] [Related]
3. Effect of sulodexide on albuminuria, NAG excretion and glomerular filtration response to dopamine in diabetic patients.
Sulikowska B; Olejniczak H; Muszyńska M; Odrowaz-Sypniewska G; Gaddi A; Savini C; Cicero AF; Laghi L; Manitius J
Am J Nephrol; 2006; 26(6):621-8. PubMed ID: 17191008
[TBL] [Abstract][Full Text] [Related]
4. [Sulodexide in the treatment of diabetic nephropathy].
Rasovskiĭ BL; Tarasov AV; Trel'skaia NIu; Severina TI; Chernykh EF
Klin Med (Mosk); 1998; 76(7):40-2. PubMed ID: 9742778
[TBL] [Abstract][Full Text] [Related]
5. One year course of oral sulodexide in the management of diabetic nephropathy.
Achour A; Kacem M; Dibej K; Skhiri H; Bouraoui S; El May M
J Nephrol; 2005; 18(5):568-74. PubMed ID: 16299683
[TBL] [Abstract][Full Text] [Related]
6. Rationale for and study design of the sulodexide trials in Type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy.
Lambers Heerspink HJ; Fowler MJ; Volgi J; Reutens AT; Klein I; Herskovits TA; Packham DK; Fraser IR; Schwartz SL; Abaterusso C; Lewis J;
Diabet Med; 2007 Nov; 24(11):1290-5. PubMed ID: 17956455
[TBL] [Abstract][Full Text] [Related]
7. Effect of sulphated glycosaminoglycans on albuminuria in patients with overt diabetic (type 1) nephropathy.
Tamsma JT; van der Woude FJ; Lemkes HH
Nephrol Dial Transplant; 1996 Jan; 11(1):182-5. PubMed ID: 8649631
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of low-dose oral sulodexide in the management of diabetic nephropathy.
Blouza S; Dakhli S; Abid H; Aissaoui M; Ardhaoui I; Ben Abdallah N; Ben Brahim S; Ben Ghorbel I; Ben Salem N; Beji S; Chamakhi S; Derbel A; Derouiche F; Djait F; Doghri T; Fourti Y; Gharbi F; Jellouli K; Jellazi N; Kamoun K; Khedher A; Letaief A; Limam R; Mekaouer A; Miledi R; Nagati K; Naouar M; Sellem S; Tarzi H; Turki S; Zidi B; Achour A;
J Nephrol; 2010; 23(4):415-24. PubMed ID: 20175052
[TBL] [Abstract][Full Text] [Related]
9. [The prognosis and control of the efficacy of heparin therapy in patients with diabetic glomerulosclerosis].
Pyrig LA; Lapchinskaia II; Belitskaia GA; Lezhen TI; Iakovenko AM; Ishchenko VM; Fedorova NE
Klin Med (Mosk); 1996; 74(2):32-5. PubMed ID: 8772099
[TBL] [Abstract][Full Text] [Related]
10. Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial.
Lewis EJ; Lewis JB; Greene T; Hunsicker LG; Berl T; Pohl MA; de Zeeuw D; Heerspink HL; Rohde RD; Atkins RC; Reutens AT; Packham DK; Raz I;
Am J Kidney Dis; 2011 Nov; 58(5):729-36. PubMed ID: 21872376
[TBL] [Abstract][Full Text] [Related]
11. Sulodexide therapy for the treatment of diabetic nephropathy, a meta-analysis and literature review.
Li R; Xing J; Mu X; Wang H; Zhang L; Zhao Y; Zhang Y
Drug Des Devel Ther; 2015; 9():6275-83. PubMed ID: 26664049
[TBL] [Abstract][Full Text] [Related]
12. Abnormal glomerular permeability characteristics in diabetic nephropathy: implications for the therapeutic use of low-molecular weight heparin.
Lewis EJ; Xu X
Diabetes Care; 2008 Feb; 31 Suppl 2():S202-7. PubMed ID: 18227486
[TBL] [Abstract][Full Text] [Related]
13. Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy.
Azadbakht L; Shakerhosseini R; Atabak S; Jamshidian M; Mehrabi Y; Esmaill-Zadeh A
Eur J Clin Nutr; 2003 Oct; 57(10):1292-4. PubMed ID: 14506491
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of alpha-defensin (-1, -2 and -3) in type 1 diabetic patients with nephropathy.
Saraheimo M; Forsblom C; Pettersson-Fernholm K; Flyvbjerg A; Groop PH; Frystyk J;
Nephrol Dial Transplant; 2008 Mar; 23(3):914-8. PubMed ID: 18003664
[TBL] [Abstract][Full Text] [Related]
15. Sulodexide improves renal function through reduction of vascular endothelial growth factor in type 2 diabetic rats.
Cha JJ; Kang YS; Hyun YY; Han SY; Jee YH; Han KH; Han JY; Cha DR
Life Sci; 2013 Jun; 92(23):1118-24. PubMed ID: 23643633
[TBL] [Abstract][Full Text] [Related]
16. Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice.
Jia ZH; Liu ZH; Zheng JM; Zeng CH; Li LS
Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):571-6. PubMed ID: 17943690
[TBL] [Abstract][Full Text] [Related]
17. [The protective effect of low molecular weight heparin on early nephropathy in diabetic rats].
Guo H; Gan L; Yu Z
Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(21):1327-9. PubMed ID: 16200729
[TBL] [Abstract][Full Text] [Related]
18. Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria.
Heerspink HL; Greene T; Lewis JB; Raz I; Rohde RD; Hunsicker LG; Schwartz SL; Aronoff S; Katz MA; Eisner GM; Mersey JH; Wiegmann TB;
Nephrol Dial Transplant; 2008 Jun; 23(6):1946-54. PubMed ID: 18089623
[TBL] [Abstract][Full Text] [Related]
19. [The kidney as a target organ in diabetic patients with arterial hypertension].
Viberti G
Drugs; 2003; 63 Spec No 1():31-7. PubMed ID: 12708880
[TBL] [Abstract][Full Text] [Related]
20. Renal Effects of Sulodexide in Type 2 Diabetic Patients without Nephrotic Range Proteinuria.
Yongwatana K; Supasyndh O; Satirapoj B
J Diabetes Res; 2020; 2020():2984680. PubMed ID: 32851094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
